# Epicutaneous 1-Chloro-2, 4-Dinitrobenzene (DNCB) Patch in HIV Infection.

> **NCT00002175** · PHASE1 · COMPLETED · sponsor: **The Honolulu Medical Group** · enrollment: 46 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Dinitrochlorobenzene

## Key facts

- **NCT ID:** NCT00002175
- **Lead sponsor:** The Honolulu Medical Group
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 46 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002175, "Epicutaneous 1-Chloro-2, 4-Dinitrobenzene (DNCB) Patch in HIV Infection.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00002175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*